PRIMED(2) Preclinical Evidence Scoring Tool to Assess Readiness for Translation of Neuroprotection Therapies

Many neuroprotective and other therapies for treatment of acute ischemic stroke have failed in translation to human studies, indicating a need for more rigorous, multidimensional quality assessment of the totality of preclinical evidence supporting a therapy prior to conducting human trials. A conse...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahr-Hosseini, Mersedeh, Bikson, Marom, Iacoboni, Marco, Liebeskind, David S., Hinman, Jason D., Carmichael, S Thomas, Saver, Jeffrey L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918446/
https://www.ncbi.nlm.nih.gov/pubmed/34196953
http://dx.doi.org/10.1007/s12975-021-00922-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918446/
https://www.ncbi.nlm.nih.gov/pubmed/34196953
http://dx.doi.org/10.1007/s12975-021-00922-4

Ejemplares similares